To enhance service offerings throughout Europe, Quintiles Transnational Corp. today announced the opening of an expanded regional facility near Edinburgh, Scotland. The purpose-built facility consolidates three buildings into a single state-of-the-art complex.
Located within the Alba Campus, a research and development center near Edinburgh, the 115,000-square-foot (10,350 square meters) building hosts more than 500 employees and has space for Quintiles' Clinical Development Services, including Project Management, Regulatory Affairs and Data Management. The facility is BREEAM (BRE Environmental Assessment Method) certified for sustainable design and low environmental impact.
The focal point of the new facility is an 80,000-square-foot (7,200 square meters) Central Laboratory that more than doubles previous capacity and allows higher throughput of clinical trial materials, including the ability to process up to three times more kits per day. Strategically located to serve the entire European region, on-site lab services include chemistry, hematology, urinalysis, serology markers, coagulation, specimen management, endocrinology and biomarkers.
“Every aspect of the building was designed to handle projects with the greatest accuracy, speed and efficiency – delivering high quality consistently to our customers,” said Tom Wollman, Senior Vice President, Global Central Laboratories. “We have the latest technology and equipment, testing standards, practices and capabilities. This allows Quintiles to anticipate and meet customer needs and safeguard patient data.”
Capitalizing on scientific advances, the facility houses one of Quintiles’ three Assay Development Labs, specializing in technical transfer of methods and assays, and validation of commercial instruments and assays for research.